Transforming Cardiac Care

The Next Step in Predicting Coronary Events

How Advanced Plaque Analysis Supports Prognosis

Webinar with Live Q&A — Watch now

How can measuring non-calcified plaque burden change how we detect heart disease?

In our tenth Transforming Cardiac Care webinar, clinical researcher Sarah Bär, MD, PhD, from Turku, Finland, explores cutting-edge findings about how the evaluation of coronary plaque with AI can reveal heart attack risk. Attendees will learn how advanced plaque analysis using machine learning algorithms compares to traditional methods of assessing cardiac health. See how tests that only measure calcified plaque, like Coronary Artery Calcium scoring, provide an incomplete view of cardiovascular risk—and see how a more comprehensive approach can better assess plaque burden.

Dr. Bär’s presentation will conclude with a Q&A session, open to all attendees.

Our Key Panelists

Sarah Bär, MD, PhD
Turku PET Centre, Turku University Hospital, Turku, Finland

Dr. Sarah Bär is a cardiologist and researcher specializing in coronary artery disease trained at Bern University Hospital, Switzerland, and University Hospital Turku, Finland. Her research focuses on integrating invasive and non-invasive methods for comprehensive assessment of coronary artery disease and advanced coronary plaque analysis.

James K. Min, MD
Founder and Chief Executive Officer, Cleerly Inc.

Dr. Min is a globally recognized authority on cardiovascular imaging and a physician-scientist who understands the inter-relationships between non-invasive imaging, coronary angiography, and revascularization.

James P. Earls, MD
Chief Medical Officer, Cleerly Inc.

Dr. Earls is a Professor of Radiology at George Washington University Hospital and a leader within the field of Radiology in applications of advanced imaging technologies in cardiovascular care.

Discussion Topics

This webinar will take a deep dive into how the presentation of coronary plaque affects long-term heart health.

Comprehensive Plaque Analysis

Learn how examining non-calcified and low-attenuation plaque can reveal more than examining calcified plaque alone.

Likelihood of ACS

See what research says about the possibility of acute coronary syndrome (ACS) in individuals with varying degrees of plaque burden.

The Power of Coronary CTA

Examine the benefits of noninvasive coronary CTA for evaluating plaque and obstructive coronary artery disease.

AI’s Role in Plaque Quantification

See how AI-enabled advanced plaque analysis can add precision to atherosclerosis measurement.

Cleerly's Transforming Cardiac Care webinar series is open to any cardiologist, radiologist, or other healthcare professional with an interest in breakthrough medtech for heart disease and prevention.